Carlos Horndler
Overview
Explore the profile of Carlos Horndler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cifuentes C, Oeste C, Fernandez-Pisonero I, Hortal A, Garcia-Macias C, Hochart J, et al.
Mol Cancer
. 2024 Jul;
23(1):142.
PMID: 38987766
Background: Breast cancer (BC) is the most common cancer in women, with triple negative BC (TNBC) accounting for 20% of cases. While early detection and targeted therapies have improved overall...
2.
Lopez-Yus M, Horndler C, Borlan S, Bernal-Monterde V, Arbones-Mainar J
Cells
. 2024 Mar;
13(5.
PMID: 38474344
Adipose tissue (AT), once considered a mere fat storage organ, is now recognized as a dynamic and complex entity crucial for regulating human physiology, including metabolic processes, energy balance, and...
3.
Lopez-Yus M, Lorente-Cebrian S, Del Moral-Bergos R, Horndler C, Garcia-Sobreviela M, Casamayor C, et al.
FASEB J
. 2022 Jul;
36(8):e22429.
PMID: 35792898
Obesity is a major risk factor for the development of Nonalcoholic fatty liver disease (NAFLD). We hypothesize that a dysfunctional subcutaneous white adipose tissue (scWAT) may lead to an accumulation...
4.
Alcedo J, Casas D, Gotor J, Lafuente M, Llorente M, Sanz-Segura P, et al.
J Gastrointestin Liver Dis
. 2021 Jun;
30(2):198-204.
PMID: 34174054
Background And Aims: Patients undergoing upper endoscopy have often used proton pump inhibitors (PPI) and/or antibiotics (ABx) recently. Both drugs have been associated with a poorer yield of the Helicobacter...
5.
Vennelaganti S, Cuatrecasas M, Vennalaganti P, Kennedy K, Srinivasan S, Patil D, et al.
Gastroenterology
. 2020 Sep;
160(1):452-454.e1.
PMID: 32950521
No abstract available.
6.
Serrablo A, Paliogiannis P, Paradisi C, Horndler C, Sarria L, Tejedor L, et al.
Dig Surg
. 2020 Apr;
37(5):383-389.
PMID: 32224622
Background: Colorectal cancer (CRC) is the most frequent gastrointestinal cancer. The liver is the organ most commonly affected by CRC metastases. Synchronous CRC liver metastases (CRCLM) are present in 15-25%...
7.
Luno V, Martinez F, Borobia M, Horndler C, Gil L
Top Companion Anim Med
. 2020 Mar;
38:100371.
PMID: 32115074
A 5-year-old male Beagle dog produced ejaculates with a high percentage of spermatozoa with abnormal morphology, especially sperm tail defects. Although libido and semen volume were normal, ejaculates showed asthenospermia,...
8.
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Codony-Servat J, Cuatrecasas M, Asensio E, Montironi C, Martinez-Cardus A, Marin-Aguilera M, et al.
Br J Cancer
. 2017 Nov;
117(12):1777-1786.
PMID: 29123263
Background: Although chemotherapy is the cornerstone treatment for patients with metastatic colorectal cancer (mCRC), acquired chemoresistance is common and constitutes the main reason for treatment failure. Monoclonal antibodies against insulin-like...
9.
Maurel J, Lopez-Pousa A, Calabuig S, Bague S, Garcia Del Muro X, Sanjuan X, et al.
Clin Sarcoma Res
. 2016 Jul;
6:10.
PMID: 27358721
Background: Most GISTs have mutations in KIT or PDGFRA. Patients with advanced GIST with KIT exon 9, PDGFRA mutation or WT for KIT and PDGFRA have a worse progression-free survival...
10.
Alonso-Espinaco V, Cuatrecasas M, Alonso V, Escudero P, Marmol M, Horndler C, et al.
Eur J Cancer
. 2014 May;
50(11):1973-81.
PMID: 24833563
Introduction: Chemotherapy is the principal treatment in metastatic colorectal cancer (mCRC) patients. RAC1b, a RAC1 spliced variant, is over-expressed in colorectal cancer (CRC), and impairs apoptosis by activation of nuclear-factor-KB....